“Natalizumab (Tysabri) in Multiple Sclerosis Patients”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 9, no. 2, June 2008, pp. 109-14, https://doi.org/10.7175/fe.v9i2.222.